top of page
AdobeStock_193266396.jpeg

GET INTO THE U.S. PAYER'S HEAD

Understand what top payers prioritize so you can develop the right evidence to eliminate coverage barriers.

Home: Projects
Understanding how top payers evaluate technologies like yours can be the difference between stalled adoption and successful market access.

A Coverage Policy Analysis gives you actionable insights into the decision-making by Medicare, Aetna, UnitedHealthcare, and more, by answering questions such as:

What is the current payer policy landscape for technologies in our category?
How do payers justify their coverage decisions, and what data do they prioritize?
What gaps in evidence need to be addressed to improve coverage likelihood?
How do cost studies influence coverage decisions?

IDENTIFY PAYER BARRIERS TO COVERAGE

Working Silhouettes

Even with established coding and national payment rates, coverage may continue to be a roadblock for your tech.

INFORM EVIDENCE GENERATION

Cataract Surgery

Align your evidence development plans with payer expectations - which are often completely different than FDA.

GAIN COMPETITIVE INTELLIGENCE

Working Together

Learn from others' successes and mistakes by knowing how similar technologies are positioned in coverage.

HOW IT WORKS
Tangible results in 2-3 weeks

01 
KICK OFF CALL

Orient us to your technology and its value proposition, and determine what a coverage analysis can surface for you.

02
POLICY SWEEP


We access, abstract, and analyze Medicare and top private payer coverage positions and their rationale. 

03
DISCUSSION

We present some considerations for your future payer positioning. All source policies are provided to you.

For further validation

GET DIRECT CONSULTATIVE GUIDANCE FROM U.S. REIMBURSEMENT STAKEHOLDERS

Untitled design (16).png
Untitled design (19).png
Untitled design (14).png
Untitled design (15).png
Untitled design (17).png
Untitled design (18).png
Coustier Advisory will facilitate interviews for you with payer decision makers, hospitals administrators, or other key reimbursement stakeholders to validate coverage findings or strategic direction for reimbursement initiatives.

Too many medtech companies line up coding and payment without lining up coverage. Don't miss the opportunity to integrate payer coverage into your early reimbursement planning.
bottom of page